Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Research article

Familial early puberty: presentation and inheritance pattern in 139 families

Authors: Adélaïde Durand, Anu Bashamboo, Ken McElreavey, Raja Brauner

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Abstract

Background

The mechanism that initiates the onset of puberty is largely unknown but the age of onset is mainly under genetic control and influenced by environmental factors including nutrition. The coexistence in the same family of central precocious puberty and advanced puberty, both representing early puberty, suggests that they may represent a clinical spectrum of the same trait due to early activation of the GnRH pulse generator. We therefore evaluated the mode of inheritance of early puberty in a large series of familial cases.

Methods

A retrospective, single center study was carried out on 154 probands (116 girls and 38 boys), from 139 families seen for idiopathic central precocious puberty (onset before 8 years in girls and 9–10 years in boys, n = 93) and/or advanced puberty (onset between 8 and 10 years in girls and 10 and 11 years in boys, n = 61) seen over a period of 8 years.

Results

Of the 139 families, 111 (80.4 %) had at least one affected 1st degree relatives, 17 (12 %) had only 2nd, 5 (3.6 %) only 3rd and 3 (2.2 %) had both 2nd and 3rd degree affected individuals. In the two remaining families, the unaffected mother had affected girls from two unaffected fathers. In the majority of families the inheritance of the phenotype was consistent with autosomal dominant mode of transmission with incomplete penetrance. An exclusively maternal mode of transmission could be observed or inferred in 83 families, paternal in only 2 families (p < 0.0001) and both maternal and paternal modes in 15 families.
In the 139 families, 374 cases of early puberty were identified of whom 315 (84.2 %) were affected females and 59 (15.8 %) affected males (p < 0.0001). Twenty one percent of families had exclusively precocious puberty, 25 % had exclusively advanced puberty and 54 % had combinations of both.

Conclusions

The data confirm the high incidence of affected girls with familial early puberty. The mode of inheritance of the phenotype is predominantly maternal. More than half of the families included both precocious and advanced puberty suggesting similar genetic factors.
Literature
1.
go back to reference Carel J-C, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123:e752–62.CrossRefPubMed Carel J-C, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, on behalf of the members of the ESPE-LWPES GnRH Analogs Consensus Conference Group. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009;123:e752–62.CrossRefPubMed
2.
go back to reference Kaprio J, Rimpelä A, Winter T, Viken RJ, Rimpelä M, Rose RJ. Common genetic influences on BMI and age at menarche. Hum Biol. 1995;67:739–53.PubMed Kaprio J, Rimpelä A, Winter T, Viken RJ, Rimpelä M, Rose RJ. Common genetic influences on BMI and age at menarche. Hum Biol. 1995;67:739–53.PubMed
3.
go back to reference Silventoinen K, Haukka J, Dunkel L, Tynelius P, Rasmussen F. Genetics of pubertal timing and its associations with relative weight in childhood and adult height: the Swedish Young Male Twins Study. Pediatrics. 2008;121:e885–91.CrossRefPubMed Silventoinen K, Haukka J, Dunkel L, Tynelius P, Rasmussen F. Genetics of pubertal timing and its associations with relative weight in childhood and adult height: the Swedish Young Male Twins Study. Pediatrics. 2008;121:e885–91.CrossRefPubMed
4.
go back to reference Towne B, Czerwinski SA, Demerath EW, Blangero J, Roche AF, Siervogel RM. Heritability of age at menarche in girls from the Fels Longitudinal Study. Am J Phys Anthropol. 2005;128:210–9.CrossRefPubMed Towne B, Czerwinski SA, Demerath EW, Blangero J, Roche AF, Siervogel RM. Heritability of age at menarche in girls from the Fels Longitudinal Study. Am J Phys Anthropol. 2005;128:210–9.CrossRefPubMed
6.
go back to reference Giabicani E, Allali S, Durand A, Sommet J, Couto-Silva A-C, Brauner R. Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study. Plos One. 2013;8:e70931.CrossRefPubMedPubMedCentral Giabicani E, Allali S, Durand A, Sommet J, Couto-Silva A-C, Brauner R. Presentation of 493 consecutive girls with idiopathic central precocious puberty: a single-center study. Plos One. 2013;8:e70931.CrossRefPubMedPubMedCentral
7.
go back to reference De Vries L, Kauschansky A, Shohat M, Phillip M. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab. 2004;89:1794–800.CrossRefPubMed De Vries L, Kauschansky A, Shohat M, Phillip M. Familial central precocious puberty suggests autosomal dominant inheritance. J Clin Endocrinol Metab. 2004;89:1794–800.CrossRefPubMed
8.
go back to reference Franceschi R, Gaudino R, Marcolongo A, Gallo MC, Rossi L, Antoniazzi F, Tato L. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty. Fertil Steril. 2010;93:1185–91.CrossRefPubMed Franceschi R, Gaudino R, Marcolongo A, Gallo MC, Rossi L, Antoniazzi F, Tato L. Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty. Fertil Steril. 2010;93:1185–91.CrossRefPubMed
9.
11.
go back to reference Tena-Sempere M. Keeping puberty on time: novel signals and mechanisms involved. Curr Top Dev Biol. 2013;105:299–329.CrossRefPubMed Tena-Sempere M. Keeping puberty on time: novel signals and mechanisms involved. Curr Top Dev Biol. 2013;105:299–329.CrossRefPubMed
12.
go back to reference Freitas KC, Ryan G, Brito VN, et al. Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent precocious puberty and isolated hypogonadotropic hypogonadism. Fertil Steril. 2007;87:627–34.CrossRefPubMed Freitas KC, Ryan G, Brito VN, et al. Molecular analysis of the neuropeptide Y1 receptor gene in human idiopathic gonadotropin-dependent precocious puberty and isolated hypogonadotropic hypogonadism. Fertil Steril. 2007;87:627–34.CrossRefPubMed
13.
go back to reference Zhao Y, Chen T, Zhou Y, Li K, Xiao J. An association study between the genetic polymorphisms within GnRHI, LHβ and FSHβ genes and central precocious puberty in Chinese girls. Neurosci Lett. 2010;486:188–92.CrossRefPubMed Zhao Y, Chen T, Zhou Y, Li K, Xiao J. An association study between the genetic polymorphisms within GnRHI, LHβ and FSHβ genes and central precocious puberty in Chinese girls. Neurosci Lett. 2010;486:188–92.CrossRefPubMed
14.
go back to reference Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab. 1999;84:415–23.PubMed Palmert MR, Malin HV, Boepple PA. Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J Clin Endocrinol Metab. 1999;84:415–23.PubMed
15.
go back to reference Pigneur B, Trivin C, Brauner R. Idiopathic central precocious puberty in 28 boys. Med Sci Monit. 2008;14:CR10–4.PubMed Pigneur B, Trivin C, Brauner R. Idiopathic central precocious puberty in 28 boys. Med Sci Monit. 2008;14:CR10–4.PubMed
16.
go back to reference Chalumeau M, Hadjiathanasiou CG, Ng SM, et al. Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr. 2003;143:445–50.CrossRefPubMed Chalumeau M, Hadjiathanasiou CG, Ng SM, et al. Selecting girls with precocious puberty for brain imaging: validation of European evidence-based diagnosis rule. J Pediatr. 2003;143:445–50.CrossRefPubMed
17.
go back to reference Armengaud J-B, Charkaluk M-L, Trivin C, Tardy V, Bréart G, Brauner R, Chalumeau M. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab. 2009;94:2835–40.CrossRefPubMed Armengaud J-B, Charkaluk M-L, Trivin C, Tardy V, Bréart G, Brauner R, Chalumeau M. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche. J Clin Endocrinol Metab. 2009;94:2835–40.CrossRefPubMed
20.
go back to reference Greulich W, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. 2nd edition. London: Oxford University Press; 1959. Greulich W, Pyle S. Radiographic atlas of skeletal development of the hand and wrist. 2nd edition. London: Oxford University Press; 1959.
21.
go back to reference Oerter KE, Uriarte MM, Rose SR, Barnes KM, Cutler Jr GB. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990;71:1251–8.CrossRefPubMed Oerter KE, Uriarte MM, Rose SR, Barnes KM, Cutler Jr GB. Gonadotropin secretory dynamics during puberty in normal girls and boys. J Clin Endocrinol Metab. 1990;71:1251–8.CrossRefPubMed
22.
go back to reference Taylor M, Couto-Silva A-C, Adan L, et al. Hypothalamic-pituitary lesions in pediatric patients: Endocrine symptoms preceed neuro-ophthalmic presenting symptoms in two thirds of cases. J Pediatr. 2012;161:855–63.CrossRefPubMed Taylor M, Couto-Silva A-C, Adan L, et al. Hypothalamic-pituitary lesions in pediatric patients: Endocrine symptoms preceed neuro-ophthalmic presenting symptoms in two thirds of cases. J Pediatr. 2012;161:855–63.CrossRefPubMed
23.
go back to reference Wohlfahrt-Veje C, Mouritsen A, Hagen CP, et al. Pubertal onset in boys and girls is influenced by pubertal timing of both parents. J Clin Endocrinol Metab. 2016;101:2667–74.CrossRefPubMed Wohlfahrt-Veje C, Mouritsen A, Hagen CP, et al. Pubertal onset in boys and girls is influenced by pubertal timing of both parents. J Clin Endocrinol Metab. 2016;101:2667–74.CrossRefPubMed
24.
go back to reference Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467–75.CrossRefPubMed Abreu AP, Dauber A, Macedo DB, et al. Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med. 2013;368:2467–75.CrossRefPubMed
25.
go back to reference Navarro VM. Interactions between kisspeptins and neurokinin B. Adv Exp Med Biol. 2013;784:325–47.CrossRefPubMed Navarro VM. Interactions between kisspeptins and neurokinin B. Adv Exp Med Biol. 2013;784:325–47.CrossRefPubMed
27.
go back to reference Bessa DS, Macedo DB, Brito VN, et al. High Frequency of MKRN3 mutations in male central precocious puberty previously classified as idiopathic. Neuroendocrinology. 2016; May 26. [Epub ahead of print]. Bessa DS, Macedo DB, Brito VN, et al. High Frequency of MKRN3 mutations in male central precocious puberty previously classified as idiopathic. Neuroendocrinology. 2016; May 26. [Epub ahead of print].
28.
go back to reference Känsäkoski J, Raivio T, Juul A, Tommiska J. A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty. Pediatr Res. 2015;78(6):709–11. doi:10.1038/pr.2015.159. Epub 2015 Sep 2.CrossRefPubMed Känsäkoski J, Raivio T, Juul A, Tommiska J. A missense mutation in MKRN3 in a Danish girl with central precocious puberty and her brother with early puberty. Pediatr Res. 2015;78(6):709–11. doi:10.​1038/​pr.​2015.​159. Epub 2015 Sep 2.CrossRefPubMed
Metadata
Title
Familial early puberty: presentation and inheritance pattern in 139 families
Authors
Adélaïde Durand
Anu Bashamboo
Ken McElreavey
Raja Brauner
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0130-x

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine